Translational Research in Malignancy Members
The Translational Research in Malignancy (TRIM) program is a highly interactive translational cancer research program. Its main objective is to conduct studies centered on molecular mechanisms of cancer progression and therapeutic resistance and to translate basic science and preclinical discoveries into early diagnosis, biomarkers, and cancer therapeutics.
Lin, Adam
Assistant Professor
Bio
Dr. Lin is a hematologist and oncologist with a clinical focus on lymphoma, cellular therapies, and stem cell transplantation. He has extensive background in nanotechnology, biomaterials to bridge the... [more]
Liu, Yan
Associate Professor
Bio
Investigating the molecular mechanisms underlying clonal hematopoiesis of indeterminate potential (CHIP), myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML)... [more]
Longnecker, Richard
Professor
Bio
Ultimately, studies by the Longnecker laboratory may provide insight for the development of novel therapeutics for the treatment of herpesvirus infections in humans and better understanding of the her... [more]
Lorch, Jochen
Professor
Bio
Dr Jochen Lorch is a medical oncologist caring for patients with head and neck cancer. He serves as the medical oncology director of the Head and Neck Cancer Program and the thyroid cancer program at... [more]
Lu, Janice
Professor
Bio
I am a Clinical Investigator specializing in the management of breast cancer. My research primarily centers on developmental therapeutics and translational aspects of breast cancer, with a focus on im... [more]
Luchtel, Rebecca A
Research Assistant Professor
Bio
My work is focused on improving our understanding of epigenetic and transcriptional regulation mechanisms contributing to tumor development, tumor-immune cell interactions, and response to therapy. My... [more]
Ma, Shuo
Professor
Bio
Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translation... [more]
Mahalingam, Devalingam
Professor
Bio
I dedicate 75% of my time to clinical research in early drug development with a focus in gastrointestinal (GI) malignancies. Through my participation in these early clinical studies, I ... [more]
Matei, Daniela
Professor
Bio
In the laboratory, specific interests have been investigating tumor-stroma interactions which regulate ovarian cancer metastasis, characterizing and targeting ovarian cancer stem cells, studying growt... [more]
Meeks, Joshua
Associate Professor
Bio
My research laboratory is focused on the molecular pathways involved in the progression of urothelial carcinoma (bladder cancer). My research has two themes: 1) to investigate the ... [more]